The regulatory green light from the European Commission marks the final clearance needed to complete Amplifon’s pending acquisition of GN’s hearing aid business, keeping the deal on track to close by year-end. Amplifon , the Milan-based global hearing care retail leader, has received approval from the European Commission for its acquisition of GN’s hearing aid business, clearing the last major regulatory hurdle...
Continue reading at Hearing Review
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate regulatory approval with no immediate effect on clinical practice.
The acquisition further consolidates the global hearing aid and retail audiology market, potentially reshaping supply relationships and competitive dynamics for independent clinics and dispensers.
- 01European Commission granted final regulatory clearance for Amplifon's acquisition of GN's hearing aid business.
- 02This was the last approval required before the deal could close.
- 03Deal is expected to close by year-end.
- 04Amplifon is already one of the world's largest hearing care retail chains.
- 05The move signals continued consolidation in the hearing aid industry.
The European Commission granted regulatory approval for Amplifon's acquisition of GN's hearing aid business.
press releasesupportedThe European Commission approval was the final clearance required to close the deal.
press releasesupportedThe deal is expected to close by year-end.
press releasepartially supported
